just keep in mind this seems to be a rogue attorney, so i would rule out a large conspiracy of an unnamed large pharma with a significant level of confidence - a large shareholder of a competitor? a connection with Heinrichs (the 1 in the 9-1 vote)? perhaps... but a stretch. my interest is, as pointed out, is the overlap of the content in the letter and the CRL.
https://www.lassmanfdalaw.com/attorneys/scott-lassman/
MSB to dispute FDA finding in Type A meeting, page-750
-
- There are more pages in this discussion • 268 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |